Atlas Trials

Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults

Clinical trial NCT03658629 · TERMINATED

Trial details

NCT number
NCT03658629
Sponsor
Novavax
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Influenza, Human
Start date
2018-09-24
Primary completion
2019-04-26
Enrollment
1375

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.